Pulmonx Corporation (NASDAQ: LUNG) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PULMONX CORPORATION

Pulmonx Corporation (NASDAQ: LUNG)
Listen to this Section


$1.26
+0.0110 ( +0.88% ) 132.7K

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Market Data


Open $1.26
Previous Close $1.25
Volume 132.7K
Market Cap $54.06M
Day Range $1.23 - $1.48
52 Week Range $1.13 - $3.88
Shares Outstanding 42.24M
Change % +0.88%
Net Change ▲ 0.0110
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -8,391.00

Date Type Amount Purchased Purchaser
2025-06-05 Buy 23321.00 Florin Daniel P
2024-08-22 Buy 14245.00 Williamson Steven S.
2024-06-26 Sale -1184.00 Rose Geoffrey Beran
2024-06-05 Sale -15216.00 Ferrari Richard
2024-06-05 Sale -15216.00 Burns Thomas William
2023-12-27 Sale -1184.00 Rose Geoffrey Beran
2023-12-22 Sale -10000.00 French Glendon E. III
2023-12-05 Sale -402.00 Lehman David Aaron
2023-12-05 Sale -135.00 McKune John
2023-12-05 Sale -396.00 Rose Geoffrey Beran

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 12, 2025
10-q Quarterly Reports 80 Nov 12, 2025
3 Insider transactions 2 Nov 10, 2025
8-k 8K-related 21 Oct 27, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Sep 03, 2025
10-q Quarterly Reports 81 Aug 01, 2025
8-k 8K-related 14 Jul 30, 2025

Latest News


× Before browsing our site, please accept our cookies policy